Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized chemoprevention study of selenium in superficial bladder cancer
2008-005431-15Phase 3Completed
- Sponsor
- KU Leuven
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of selenium in bladder cancer and transitional cell carcinoma of the bladder (TCC) (2 arms), sponsored by KU Leuven. Primary endpoint: Recurrence-free interval. Started Sep 2008; status: completed.
02
Drugs
selenium
03
Conditions
bladder cancertransitional cell carcinoma of the bladder (TCC)
Beyond the preview
Go deeper on 2008-005431-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005431-15.